Cardinal Health (CAH) Shares Outstanding (Weighted Average) (2009 - 2026)
Cardinal Health's (CAH) quarterly Shares Outstanding (Weighted Average) came in at $235.0 million in Q1 2026, down 2.08% year-on-year from $240.0 million in Q1 2025, and little changed quarter-over-quarter from $236.0 million in Q4 2025.
Cardinal Health (CAH) Shares Outstanding (Weighted Average) (2009 - 2026) Analysis & Trends
Cardinal Health has disclosed Shares Outstanding (Weighted Average) across 18 years of filings, most recently posting $235.0 million for Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $235.0 million, down 2.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $235.0 million (down 2.08% YoY), and the FY2025 annual result was $241.0 million, down 1.63% from the prior year.
- Shares Outstanding (Weighted Average) came in at $235.0 million for Q1 2026 at Cardinal Health, roughly flat from $236.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $281.0 million in Q1 2022 to a low of $235.0 million in Q1 2026.
- The 5-year median for Shares Outstanding (Weighted Average) is $245.0 million (2023), against an average of $250.9 million.
- Across the five-year window, Shares Outstanding (Weighted Average) decreased 8.9% in 2023 and retreated 1.22% in 2024, its largest moves.
- Cardinal Health's Shares Outstanding (Weighted Average) stood at $261.0 million in 2022, then slipped by 6.13% to $245.0 million in 2023, then declined by 1.22% to $242.0 million in 2024, then retreated by 2.48% to $236.0 million in 2025, then decreased by 0.42% to $235.0 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $235.0 million (Q1 2026), $236.0 million (Q4 2025), and $238.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 1,767,296.88 Bn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 123.60 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 194.38 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 235.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 114.94 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 76.43 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 37.48 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 24.54 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 47.09 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 14.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 235.00 Mn |
| Dec 31, 2025 | 236.00 Mn |
| Sep 30, 2025 | 238.00 Mn |
| Jun 30, 2025 | 241.00 Mn |
| Mar 31, 2025 | 240.00 Mn |
| Dec 31, 2024 | 242.00 Mn |
| Sep 30, 2024 | 243.00 Mn |
| Jun 30, 2024 | 245.00 Mn |
| Mar 31, 2024 | 243.00 Mn |
| Dec 31, 2023 | 245.00 Mn |
| Sep 30, 2023 | 249.00 Mn |
| Jun 30, 2023 | 261.00 Mn |
| Mar 31, 2023 | 256.00 Mn |
| Dec 31, 2022 | 261.00 Mn |
| Sep 30, 2022 | 271.00 Mn |
| Jun 30, 2022 | 279.00 Mn |
| Mar 31, 2022 | 281.00 Mn |
| Dec 31, 2021 | 283.00 Mn |
| Sep 30, 2021 | 287.00 Mn |
| Jun 30, 2021 | 292.00 Mn |